BCAL Diagnostics Ltd
ASX:BDX
Balance Sheet
Balance Sheet Decomposition
BCAL Diagnostics Ltd
BCAL Diagnostics Ltd
Balance Sheet
BCAL Diagnostics Ltd
| Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
3
|
6
|
3
|
6
|
5
|
|
| Cash |
0
|
0
|
0
|
3
|
6
|
3
|
6
|
5
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
3
|
3
|
3
|
|
| Total Current Assets |
1
|
1
|
1
|
4
|
10
|
6
|
9
|
7
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
-4%
|
1
+52%
|
4
+404%
|
11
+156%
|
8
-21%
|
12
+47%
|
10
-19%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
2
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
0
-92%
|
0
+631%
|
1
+38%
|
1
+81%
|
3
+232%
|
4
+16%
|
4
+0%
|
|
| Equity | |||||||||
| Common Stock |
3
|
4
|
5
|
9
|
19
|
19
|
29
|
34
|
|
| Retained Earnings |
4
|
4
|
5
|
6
|
9
|
14
|
20
|
28
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
-10%
|
4
+722%
|
10
+167%
|
5
-46%
|
9
+65%
|
6
-28%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
-4%
|
1
+52%
|
4
+404%
|
11
+156%
|
8
-21%
|
12
+47%
|
10
-19%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
207
|
207
|
207
|
207
|
207
|
212
|
314
|
366
|
|